Editorial Board
Editor-In-Chief
Jeffrey M. Peters
University Park, PA
Distinguished Professor of Molecular Toxicology and Carcinogenesis
Deputy Director, The Penn State Cancer Institute
The Pennsylvania State University
Dr. Peters' research interests include soluble receptor-mediated mechanisms of toxicity and carcinogenesis, peroxisome proliferator-activated receptors, cancer chemoprevention and chemotherapy, and transcriptional regulation.
Email: [email protected]
Deputy Editor

Kristie Willett
Oxford, MS
Chair of BioMolecular Sciences
Professor of Pharmacology and Environmental Toxicology
University of Mississippi
Dr. Willett's research interests include polycyclic aromatic hydrocarbons, developmental basis of adult disease, zebrafish, and environmental toxicology.
Associate Editors
Jason Cannon
West Lafayette, IN
Professor of Toxicology
Purdue University
Dr. Cannon’s research interests include neurotoxicology, mechanisms of environmentally induced neurodegeneration, gene-environment interactions, and increasing translational connections between model systems and human studies to advance understanding of neurological diseases.
Nathan Cherrington
Tucson, AZ
Professor of Pharmacology and Toxicology
University of Arizona
Dr. Cherrington's research interests include inter-individual variability in drug metabolism and disposition, and drug transport at the blood-testis barrier.

Chris Corton
Research Triangle Park, NC
Research Biologist
Environmental Protection Agency
Dr. Corton’s interests include chemical carcinogenesis, toxicogenomics, biomarkers, systems toxicology, and high-throughput testing.
Julia Cui
Seattle WA
University of Washington
Brian Cummings
Detroit, MI
Dean and Professor
Eugene Applebaum College of Pharmacy and Health Sciences
Dr. Cummings research interest include nephrotoxicity, cell death, chemotherapeutics, lipidomics, and phospholipases.

Dana Dolinoy
Ann Arbor, MI
NSF International Chair & Professor of Environmental Health Sciences
University of Michigan School of Public Health
Dr. Dolinoy's research interests include epigenomics and the developmental origins health and disease, toxicoepigenetics, endocrine disrupting chemicals, and epigenome editing.
Bengt Fadeel
Stockholm, Sweden
Professor of Medical Inflammation Research
Institute of Environmental Medicine, Karolinska Institutet
Dr. Fadeel’s research interests include nanotoxicology, in particular in vitro based approaches, immunotoxicology, and mechanisms of cell death.

Jodi Flaws
Urbana, IL
Professor of Comparative Biosciences
University of Illinois
Dr. Flaws' research interests include ovarian toxicology, female reproductive toxicology, women's health, and endocrine disrupting chemicals.

Kymberly Gowdy
Columbus, OH
Associate Professor in the Department of Internal Medicine
Ohio State University Wexner Medical Center
Ohio State University, Columbus, OH, USA
Dr. Gowdy's research interests include pulmonary and immunotoxicology, sir pollution exposure, innate immunity, pattern recognition receptors, lipid metabolism, host defense, and resolution of inflammation and injury.
Nigel Greene
Mystic, CT
Vice President of Toxicology, Recursion Pharmaceuticals
Dr Greene’s research interests include the application of machine learning and artificial intelligence methods to understand the structural basis of drug-induced toxicity, understanding their mechanisms from high-content data sets such as transcriptomics as well as their translation to clinical patient populations.
Bethany Hannas
Eli Lilly and Co
Rhiannnon Hardwick
San Diego, CA
Scientific Associate Director, Discovery Toxicology
Bristol Myers Squibb
Dr. Hardwick is a project toxicologist and laboratory team lead. In addition to her focus in drug discovery, her research interests include qualification and application of complex in vitro models and microphysiological systems, mechanistic toxicology, and drug-induced hepatic, gastrointestinal, ocular, and hematopoietic toxicity.
Catrin Hasselgren
Genentech Inc

Hartmut Jaeschke
Kansas City, KS
Professor and Chair of Pharmacology, Toxicology & Therapeutics
University of Kansas Medical Center
Dr. Jaeschke's research interest include basic and translational aspects of drug hepatotoxicity, obstructive cholestasis, alcoholic hepatitis, and hepatic ischemia-reperfusion injury.

Yiguo Jiang
Guangzhou, China
Professor of Toxicology
Guangzhou Medical University, China
Dr. Jiang's research interests include environmental toxicology, chemical carcinogenesis, and noncoding RNA.
Samir Kelada
University of North Carolina at Chapel Hill
Dr. Kelada’s research is focused on identifying genetic and genomic predictors of respiratory responses to ambient air pollutants, primarily using mouse models.

Yoshito Kumagai
Tsukuba, Japan
Professor of Environmental Biology
Faculty of Medicine
University of Tsukuba
Dr. Kumagai's research interests include chemical toxicology, modulation of signal transduction pathways, covalent binding, electrophiles and reactive sulfur species.

B. Paige Lawrence
Rochester, NY
Professor of Environmental Medicine and Microbiology & Immunology
University of Rochester
Dr. Lawrence's research interests include immunotoxicology, host-pathogen interactions, aryl hydrocarbon receptor, developmental programming, stem cells, and epigenetics.
Ulrike Luderer
Irvine, CA
Professor of Medicine, Developmental and Cell Biology, and Public Health
Director, Center for Occupational and Environmental Health
University of California Irvine
Dr. Luderer's research interests include female reproductive toxicology with a focus on mechanisms of ovarian toxicity, developmental toxicology of the reproductive system, developmental origins of reproductive disease and dysfunction, and the roles of oxidative stress in ovarian aging.

Edward V. Ohanian
Washington, DC
Associate Director for Science
U.S. Environmental Protection Agency
Dr. Ohanian's research interests include science policy and regulatory toxicology, new and improved human risk assessment methodologies, and risk characterization in informed regulatory decision making.
Andrew Ottens
Richmond, VA
Associate Professor Anatomy and Neurobiology
Virginia Commonwealth University
Dr. Ottens’ research interests include neurotoxicology and its mechanistic interface with inhalation toxicology as related to nanoparticulates and air pollution.

Marc Pallardy
Chatenay Malabry, France
Professor of Toxicology
Faculty of Pharmcy
University Paris-Sud, France
Dr. Pallardy's research interests include Immunotoxicology, allergy, cell signaling, and biologics.

Andrew D. Patterson
University Park, PA
Professor, Department of Veterinary and Biomedical Sciences, Department of Biochemistry and Molecular Biology
The Pennsylvania State University
Dr. Patterson’s research interests include nuclear receptor biology, metabolism, and host-microbiome interactions.
Jason R. Richardson
Atlanta, GA
Sobh Professor of Physiology and Pharmacology
Center for Neurological Disease Research
College of Veterinary Medicine, University of Georgia
Dr. Richardson’s interests include gene-environment interactions in neurotoxicity and neurological disease, pesticides, epigenetics, glial biology, neuroinflammation, and developmental neurotoxicology.

Ruth Roberts
Alderley Edge, UK
Director, ApconiX and Professor of Drug Discovery
University of Birmingham, UK
Dr Roberts is an expert on the toxicology of drug discovery and development as well as molecular and mechanistic toxicology.

Ivan Rusyn
College Station, TX
University Professor of Veterinary Integrative Biosciences
Chair, Interdisciplinary Faculty of Toxicology
Director, Superfund Research Center
Texas A&M University
Dr. Rusyn’s research interests include development of and testing of alternative methods for toxicity testing, application of in vitro and animal-based models to evaluate inter-individual variability in responses to drugs and environmental chemicals, computational toxicology, and studies of the effects of environmental chemicals on genome biology.
Robyn Tanguay
Corvallis, OR
Distinguished Professor of Molecular Toxicology
Oregon State University
Dr. Tanugay's research interest include systems and molecular toxicology with an emphasis in the areas of developmental and neurotoxicology using the zebrafish model.

Laura S. Van Winkle
Davis, CA
Professor of Respiratory Toxicology
University of California, Davis
Dr. Van Winkle's research interests include inhalation toxicology, respiratory biology, lung development, xenobiotic metabolism, lung cancer, and asthma.
Seth Walk
Professor, Department of Microbiology and Cell Biology
Montana State University
Dr. Walk’s research interests include biotransformation of heavy metals and metalloids by the gut microbiome, including arsenic, antimony, and methylmercury.
Daniele Wikoff
Asheville, NC
Health Sciences Practice Leader
ToxStrategies, Inc.
Dr. Wikoff's research interests include systematic reviews and other evidence-based methodologies to support transparent assessment of hazards and risks, techniques for critical appraisal of study quality, and utilization of qualitative and quantitative techniques to integrate data across evidence streams.
George Woodall
Research Triangle Park, NC
Hazardous Pollutant Assessment Group
United States Environmental Protection Agency
Dr. Woodall's research interests include human health risk assessment, inhalation toxicology, and mechanisms of carcinogenesis. He has also been pursuing efforts to effectively manage toxicological data for application in advanced analysis to support risk assessments.
Chengfeng Yang
Lexington, KY
Professor, Dept of Toxicology and Cancer Biology
University of Kentucky
Dr. Yang’s research interests include cancer biology, cancer metastasis, environmental carcinogenesis, metal toxicity and carcinogenesis, epigenetics, non-coding RNAs, and functional RNA modifications.

Qiang Zhang
Atlanta, GA
Associate Professor, Computational Toxicology
Emory University
Dr. Zhang’s research is focused on using computer simulations of biological systems to understand and predict the human health effects of environmental perturbations. Research interests include nonlinear dose-response relationships, systems biology pathway modeling, PBPK/PD modeling, endocrine disruptors, redox biology, and in vitro toxicity testing.
Youcai Zhang
Tianjin, China
Professor
Lead of Pharmacology and Toxicology
School of Pharmaceutical Science and Technology
Tianjin University
Dr. Zhang’s research interests include liver and kidney toxicology, drug transporters, drug-drug interactions, liver carcinogenesis, fatty liver diseases, colorectal cancer, lipid metabolism and biomarker discovery.
Managing Editor
Virginia F. Hawkins, Reston, VA
Toxicological Sciences Editorial Office
11190 Sunrise Valley Drive, Suite 300
Reston, VA 20191
302-326-9313 phone
Email: [email protected]
Editorial Board
Lauren Aleksunes, Rutgers University, Piscataway, NJ
Scott Auerbach, National Institute of Environmental Health Sciences, Research Triangle Park, NC
Robert Barouki, Inserm, Paris, France
Jones Bernardes Graceli, Southern Illinois University, Carbondale, IL
Alessandro Brigo, F Hoffmann-La Roche, Basel Switzerland
Alex Carll, University of Louisville, Louisville, KY
Chi Chen, University of Minnesota, St. Paul, MN
Minjun Chen, US FDA National Center for Toxicology Research, Jefferson, AR
Andrea de Vizcaya-Ruiz, University of California Irvine, Irvine, CA
Marcelo Farina, Universidade Federal de Santa Catarina, Florianopolis, Brazil
Mary Gilbert, US Environmental Protection Agency, Durham, NC
Peter L. Goering, US Food and Drug Administration, Silver Spring, MD
Emily Golden, SRC, Inc., North Syracuse, NY
Daniel Gorelick, Baylor College of Medicine, Houston, TX
Haiwei Gu, Arizona State University, Phoenix, AZ
Petra Haberzettl, University of Louisville, Louisville, KY
Jeffrey A. Handler, Diagonal Therapeutics, Watertown, MA
Joseph Hanig, US Food and Drug Administration, Silver Spring, MD
Muhammad Hossain, Florida International University, Miami, FL
Todd Jusko, University of Rochester, Rochester, NY
Barbara Kaplan, Mississippi State University, Mississippi State, MS
Agnes Karmaus, Syngenta Crop Protection, Greensboro, NC
Nicholas Kenyon, US Environmental Protection Agency, Sacramento, CA
Saadia Kerdine-Römer, Université de Paris, Paris, France
Urmila Kodavanti, US Environmental Protection Agency, Research Triangle Park, NC
Aleksandra Kuzamanov, Lawrence Technological University, Southfield, MI
Lawrence Lash, Wayne State University, Detroit, MI
Betina J. Lew, Johnson & Johnson Medical Devices, Yardley, PA
John C. Lipscomb, CTEH, Little Rock, AR
Bin Liu, University of Florida, Gainesville, FL
Cuiqing Liu, Zhejiang Chinese Medical University, Hanghzou, China
Amie K. Lund, University of North Texas, Denton, TX
James Luyendyk, Michigan State University, East Lansing, MI
Jonathan Maher, Pliant Therapeutics, South San Francisco, CA
Megan Mahoney, University of Illinois Urbana-Champaign, Urbana, IL
Mitchell McGill, University of Arkansas, Little Rock, AR
Lisa Miller, University of California Davis, Davis, CA
Dean Naisbitt, University of Liverpool, Liverpool, UK
Tara M. Nordgren, Colorado State University, Fort Collins, CO
Andrew Olaharski, Erasca, Winchester, MA
Gary Perdew, The Pennsylvania State University, University Park, PA
Lori Raetzman, University of Illinois at Urbana Champaign, Urbana, IL
Julia Rager, University of North Carolina at Chapel Hill, Chapel Hill, NC
Meghan Rebuli, University of North Carolina at Chapel Hill, Chapel Hill, NC
Christopher Reilly, University of Utah, Salt Lake City, UT
Bernard Robaire, McGill University, Montreal, Canada
Amy Roe, Procter & Gamble Company, Williamstown, KY
James Roede, University of Colorado, Aurora, CO
Wellerson Scarano, São Paulo State University UNESP, Washington, DC
Edward Schelegle, University of California Davis, Davis, CA
Dieter Schrenk, University of Kaiserslautern, Kaiserslautern, Germany
Jonathan H. Shannahan, Purdue University, West Lafayette, IN
Kan Shao, Indiana University, Bloomington, IN
Yueting Shao, Guangzhou Medical University, Guangzhou, China
Cody Smith, Rutgers University, Hartford, CT
Phoebe Stapleton, Rutgers University, Piscataway, NJ
Erik Tokar, National Institute of Environmental Health Sciences, Durham, NC
Monica Valentovic, Marshall University, Huntington, WV
Almudena Veiga-Lopez, University of Illinois at Chicago, Chicago, IL
Kendall B. Wallace, University of Minnesota Medical School Duluth, MN
Zhishan Wang, Stony Brook University, Stony Brook, NY
David B. Warheit, Newark, DE
Caren Weinhouse, Oregon Health & Science University, Portland, OR
Georg Wondrak, University of Arizona, Tucson, AZ
Shuo Xiao, Rutgers University, Princeton, NJ
Xi Yang, RTI International, Research Triangle Park, NC
Yunhan Yang, Southeast University, Nanjing, China
Dianke Yu, Qingdao University, Qingdao, China
Anatoly Zhitkovitch, Brown University, Providence, RI
Ayelet Ziv-Gal, University of Illinois Urbana-Champaign Urbana, IL
Katherine Zychowski, University of New Mexico, Albuquerque, NM
Editors Emeriti
Curtis D. Klaassen, 1998–2003
Lois D. Lehman-McKeeman, 2003–2011
Michael L. Cunningham, 2011–2013
Gary W. Miller, 2013–2019
Fundamental and Applied Toxicology
William W. Carlton
Henry d'A. Heck
Bernard A. Schwetz
Philip G. Watanabe
Board of Publications, Society of Toxicology
Deborah Cory-Slechta, University of Rochester Medical Center, Rochester, NY, Chair
Barbara L.F. Kaplan, Mississippi State University, Mississippi State, MS, Co-Chair
Laurie Haws, ToxStrategies, Inc, Austin TX, Council President
Cynthia V. Rider, Council Vice-President, Ex-Officio
Michael DeVito, US Environmental Protection Agency, Research Triangle Park, NC
Jennifer Schlezinger, Boston University School of Public Health, Boston, MA
Annual Meetings
2026 March 22–25, San Diego, California
2027 March 14-17, San Antonio, Texas
2028 March 19-22, Nashville, Tennessee